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Neural regeneration
ProteoglycansNerve fibers of the peripheral nervous system (PNS) have a remarkable ability to regenerate up to an
almost complete recovery of normal function following a crush or a Sunderland Type II injury. This pro-
cess is governed by glial cells, known as Schwann cells, through their unique capacity to dedifferentiate
into cells that drive the healing process. Despite that many progresses have occurred in restorative med-
icine and microsurgery, the regenerative process after a severe lesion of a major nerve trunk (e.g.,
Sunderland Types III-V) is often incomplete and functional recovery is unsatisfactory. In this aspect, it
is known that glycosaminoglycans (GAGs) of the extracellular matrix are involved in proliferation, synap-
togenesis, neural plasticity, and regeneration of the PNS. Here, we developed poly(caprolactone) (PCL)
fibrous scaffolds functionalized with GAGs, which allowed us to assess their influence on the adhesion,
proliferation, and differentiation of Schwann cells. We found that both aligned and random fiber scaffolds
functionalized with GAGs resulted in increased cell proliferation on day 1. In addition, aligned function-
alized scaffolds also resulted in increased GAG presence on day 1, probably because of cell extracellular
matrix (ECM) formation and an increased syndecan-4 expression on day 7. A different modification and
activation of Schwann cells in the presence of GAG versus no-GAG scaffolds was underlined by proteomic
comparative analysis, where a general downregulation of the expression of intracellular/structural and
synthetic proteins was shown on day 7 for GAG-functionalized scaffolds with regard to the nonfunction-
alized ones. In conclusion, we have shown that GAG-functionalized scaffolds are effective in modulating
Schwann cell behavior in terms of adhesion, proliferation, and differentiation and should be considered in
strategies to improve PNS repair.
Statement of Significance
Nerve fibers functional recovery following a severe trauma of the Peripheral Nervous System (PNS) still
represents a huge challenge for neurosurgery nowadays. In this respect, tissue engineering is committed
to develop new constructs able to guide Schwann cells by mimicking the natural extracellular matrix
environment. To this purpose, we successfully fabricated polycaprolactone (PCL) scaffolds with two
well-defined fiber deposition patterns, functionalized with glycosaminoglycans (GAGs) and assessed
for their potential as support for Schwann cells adhesion, growth and differentiation, by both classical
biochemistry and LC-MS-based proteomic profiling. By this way, we showed that PCL–GAGs scaffolds
could represent a promising artificial substrate that closely mimics the recently established pattern of
Schwann cells migration into the regenerating nerve and, therefore, it should be considered in strategies
to improve PNS repair.
 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
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Nerve recovery from peripheral nerve trauma depends on dif-
ferent factors including the extent of the lesion, time course, and
recovery following nerve injury. When a peripheral nerve under-
goes a traumatic injury, several pathophysiological processes occur
at the proximal and distal segments of the injury site, as well as in
the nerve cell body and the distal endings of both muscle end
plates and sensory receptors. Changes in the nerve at the site of
injury begin almost immediately, and the healing process is guided
by the glial cells of the peripheral nervous system (PNS), called
Schwann cells, which are critical in the regeneration of a mature
nerve [1]. However, when the gap between proximal and distal
segments is too large, complete self-regeneration is not possible
and microsurgical intervention is essential for nerve repair [2–4].
The current ‘‘golden standard” to treat neural defects employs
autologous grafts [5–7]. However, autografts have limitations,
which include shortage of nerves, as they are taken from the same
patient, a mismatch between the sizes of the donor site and the
recipient site, neuroma formation, and lack of functional recovery
[8,9]. An alternative to autografts is the use of allogenic grafts iso-
lated from cadavers. These grafts, however, may undergo host–
graft immune rejection [10]. To overcome this limitation, several
studies have been conducted to evaluate the efficiency of acellular
nerve grafts [11,12].
In the last few years, some disciplines such as nanotechnology
[13,14] and tissue engineering [15–18] have focused on this issue.
The major challenge in tissue engineering is to develop a synthetic
support structure, or scaffold, that is able to mimic the natural
extracellular matrix (ECM). A synthetic ECM should have several
features including biocompatibility, controlled biodegradability
with nontoxic products, low inflammatory potential, porosity pro-
moting cell attachment and growth, and mechanical properties
similar to those of the tissue to be replaced [19–21]. In these
aspects, polymeric biomaterials are widely used for scaffold fabri-
cation. Presently, there is a vast choice of both synthetic polymers
and natural materials displaying the required properties men-
tioned above [22], but few clinically approved nerve conduits are
available [23–25]. Several techniques have been used to fabricate
tissue engineering scaffolds such as electrospinning, nanofiber
self-assembly, liquid–liquid phase separation, solvent casting and
particulate leaching, emulsification/freeze-drying, gas foaming,
and additive manufacturing [26–29].
Biocompatibility of engineered scaffolds could be further
enhanced by surface modification of the material, in particular,
by attaching bioactive molecules. Glycosaminoglycans (GAGs) are
a family of highly charged, unbranched heteropolysaccharides that
play key roles as structural and functional components of the
extracellular matrix. Except for hyaluronic acid (HA), they are vari-
ably sulfated and covalently linked to protein cores, thereby form-
ing proteoglycans (PGs). GAGs are structurally very heterogeneous
in terms of both type and number of repeating disaccharide build-
ing blocks, degree and pattern of sulfation, and degree of hexuronic
acid epimerization. Numerous biological functions of PGs, such as
cell interactions, differentiation, proliferation, and matrix assem-
bly, mainly depend on specific structural characteristics of their
GAG chains in both physiological and pathological conditions
[30,31].
In the central nervous system (CNS), sulfated proteoglycans
such as chondroitin sulfate proteoglycans (CSPGs), dermatan sul-
fate proteoglycans (DSPGs), keratan sulfate proteoglycans (KSPGs),
and heparan sulfate proteoglycans (HSPGs) represent major func-
tional constituents of the extracellular matrix [32–34]. They have
a role in several physiological processes. For example, during
embryonic development, they stimulate processes such asneuronal adhesion, migration, and neurite formation [35–38].
Additionally, they are involved in the restoration of neuronal func-
tion following a trauma, and their effects strictly depend on struc-
tural characteristics of GAGs. In particular, the hyalectan CSPG
family inhibits neuritogenesis, whereas other PGs containing disul-
fated CS disaccharide units (4-O-sulfate or 6-O-sulfate) or oversul-
fated DS disaccharide units are neurostimulatory and promote
repair processes [34].
Interestingly, in the PNS, it has been found that, after a periph-
eral nerve injury, chondroitin 6-sulfotransferase-1 (C6ST-1) is
upregulated, suggesting that an increase in 6-sulfated GAGs makes
the ECMmore prone to axonal regeneration, and the balance of dif-
ferent CS GAGs in the microenvironment around the lesion is an
important factor in determining the response of the nervous sys-
tem after injury [39,40]. On the other hand, it has been reported
that chondroitin ABC lyase treatment may promote axonal regen-
eration in both CNS and spinal cord tissues [41,42]. Porous PDLLA
scaffolds [43], hydrogels [44–46], and carbon nanotubes [47] func-
tionalized with CS have been fabricated, representing promising
constructs for neuronal regeneration.
The aim of this study was to evaluate the response of Schwann
cells grown on electrospun scaffolds functionalized with specific
GAGs purified from the aorta porcine tissue. In this aspect, under-
standing whether GAGs can improve proliferative activities and
binding capacities of the cells to the scaffolds could be promising
to improve the process of nerve regeneration. Proliferation, meta-
bolic activity, and GAG assays were performed. The expression of
specific markers (i.e., Syndecan 1, Syndecan 4, Integrin a9b1, Lami-
nin, and p75) during 7 days of culture was evaluated by both
immunofluorescence and western blot analyses. Furthermore, a
proteomic approach was applied for the evaluation of eventual
specific patterns of protein expression after 3 days and 7 days of
culture.
2. Materials and methods
2.1. Preparation of electrospun scaffolds
Electrospinning produces a sheet of fibers by pushing a liquid
jet through a nozzle under an electric field [48–53]. Electrospun
polycaprolactone (PCL, 45 kDa, Sigma-Aldrich, Germany) fiber
mats used as fibrous scaffolds were fabricated by electrospinning
from a 15% (w/v) PCL solution in 1:4 (v/v) dimethylformamide
(DMF): chloroform. A blunt 20-gauge stainless steel hypodermic
needle (o.d. 0.8 mm, Unimed, Switzerland) was used as the nozzle.
A polyurethane nonwoven mesh (a kind gift from Lantor B.V., The
Netherlands) and an aluminum foil wrapped around a rotating
cylinder (cylinder size = o.d. 6 cm, length 19 cm) were used as
the collector. The working distance from the tip of the needle to
the surface of the aluminum sheet was 14 cm. A high-voltage
power supply (Gamma High Voltage Research Inc., FL, USA) was
used to generate a direct current potential of 20 kV. The emitting
electrode of positive polarity was connected to the needle, while
the grounding one was connected to the collector. The feed rate
of the PCL solution was controlled using a syringe pump (KDS
100, KD Scientific) at 1 mL/h. A 60 mm diameter mandrel speed
was rotated at 500 rpm (2.6 V) to obtain scaffolds with random
fibers and approximately 4000 rpm (9 V) to obtain scaffolds with
aligned fibers. The needle was set to move back and forth along
the length of the cylinder to permit homogeneous fiber deposition
on top of the polyurethane sheet. After continuous spinning for
15 min, homogenous PCL fibrous scaffolds were obtained. The
morphology of the fibrous scaffolds and the size of the individual
fiber segment therein were examined using a Philips XL30 scan-
ning electron microscope. Multiple scanning electron microscopy
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analyzed using Fiji image processing package (GNU General Public
License), by which the mean value of the diameters of the fiber seg-
ments within the PCL fibrous scaffolds was determined (five differ-
ent fibers in distinct points of each image in quadruplicate for each
condition, resulting in at least 20 fibers per scaffold group).
2.2. Glycosaminoglycans purification
GAGs were purified as described by Naso et al. [54] and Cigliano
et al. [55]. In brief, porcine aortic root from 10- to 12-month-old
pigs were obtained from a local slaughterhouse. Fatty adherences
were removed from aortic tissue by gentle peeling. The wet weight
of each sample was determined after gently blotting with a filter
paper. Aortic minced tissues were dehydrated with 20 volumes
of acetone at 4 C for 24 h, defatted with 20 volumes of chloro-
form:methanol (2:1, v/v) at 4 C for 24 h, dried for 24 h at 60 C
after centrifugation at 3300g for 15 min, and finally weighed
(dry-defatted tissue (DDT) weight). DDTs were rehydrated for
24 h at 4 C in 0.1 M sodium acetate buffer, pH 5.8, containing
5 mM cysteine, and 5 mM ethylenediaminetetraacetic acid (EDTA)
(37 volumes per gram of DDT). Then, papain (0.3 U/mg of DDT) was
added to the mixture, which was incubated at 56 C for 48 h. The
digestion was stopped by boiling the solution at 100 C for 5 min,
followed by centrifugation (9000g for 15 min at 4 C). The super-
natant was loaded on a diethylaminoethyl (DEAE) Sephacel column
(1.5  50 cm, 70 mL), equilibrated with a 50 mM sodium acetate
buffer, pH 6.0. The column was then exhaustively washed with
the same buffer (absorbance of flow-through fraction at 280 nm
<0.05) and GAGs eluted with a 50 mM sodium acetate buffer, pH
6.0, containing 1.5 M NaCl. Fractions of 5 mL were collected and
assayed for hexuronic acid (UA) content by the method of Bitter
and Muir, using glucuronolactone as a standard [56]. GAG-
containing fractions were pooled and precipitated using 4 volumes
of cold absolute ethanol. The mixture was left overnight at 20 C,
and the precipitate was separated by centrifugation, washed twice
with ethanol, and then dried. GAG composition was determined by
discontinuous cellulose acetate electrophoresis [57]. Alcian blue-
stained strips were acquired (Gel Doc XR System) and analyzed
using Quantity One 4.6.3 software (Bio-Rad Laboratories).
Fine structural characterization of CS isomers was performed as
previously described [58]. Briefly, following chondroitin ABC lyase
treatment of CS isomers, unsaturated disaccharide units were flu-
orescently tagged with 2-aminoacridone and resolved by
fluorophore-assisted carbohydrate electrophoresis (FACE). Images
were acquired by UV transillumination (Gel Doc XR System) and
analyzed by using Quantity One 4.6.3 software (Bio-Rad
Laboratories).
2.3. Electrospun scaffold functionalization
PCL scaffolds were first aminolysed and then functionalized
with GAGs (Supplementary Information, Fig. S1). First, dried
scaffolds were incubated for 1 h at 37 C with 5%
1,6-hexamethylenediamine (HMDA) in isopropanol and then
washed three times with water. GAGs purified from porcine aorta
tissue (100 lg UA solubilized in 100 lL H2O) were added to each
scaffold. As control, nonfunctionalized (nude) scaffolds were used;
in this case, 100 lL of water was added. A solution of 50 mM N-(3-
dimethylaminopropyl)-N0-ethylcarbodiimide hydrochloride (EDC)/
N-hydroxysuccinimide (NHS) in 2-(N-morpholino)ethanesulfonic
acid (MES) was added in each scaffold and left overnight at room
temperature. Before seeding, nonfunctionalized and functionalized
scaffolds (o.d. 15 mm) were placed into a 24-well nontreated tissue
culture plate (VWR). Each scaffold was pushed to the bottom of the
well with O-rings (Eriks BV, The Netherlands) to prevent cells frommigrating out of the scaffolds onto the culture plate. Afterwards,
supplemented (L-glutamine, FBS, penicillin-streptomycin) DMEM
was added in each well, and the plate was incubated at 37 C with
5.0% CO2 for 24 h. To assess the degree of GAG functionalization, an
Alcian blue staining protocol was developed. In brief, scaffolds
were placed in a 24-well-plate and stained with Alcian blue solu-
tion (0.1% Alcian blue, 10% EtOH, 0.1% CH3COOH, 0.03 M MgCl2 in
water) for 30 min at room temperature. Then, the scaffolds were
washed with Alcian blue destaining solution (10% EtOH, 0.1%
CH3COOH, 0.03 MMgCl2 in water) for 30 min at room temperature.
To dissolve Alcian blue bound to the GAGs linked to the scaffolds, a
solution of 1% SDS (w/v) was added into each well, and the plate
was left shaking (200 rpm) for 30 min. The supernatant was trans-
ferred into a new well plate, and absorbance at 605 nm was read
with the CLARIOstar plate reader (BMG Labtech).
2.4. Cell culture studies
Four types of constructs were produced for cell culture studies:
scaffolds with random fibers (R), random fibers functionalized with
GAGs (RG), aligned fibers (A), and aligned fibers functionalized
with GAGs (AG).
Neuronal Schwann cells RT4-D6P2T (ATCC CRL-2768TM) were
maintained in DMEM high glucose (Thermo Fisher Scientific) sup-
plemented with 2 mM L-glutamine (Thermo Fisher Scientific), 10%
fetal bovine serum (FBS; Sigma), and penicillin–streptomycin (100
U/mL; Sigma). Cells were removed from the culture flasks using a
trypsin-EDTA solution (Sigma) after reaching confluence. Before
seeding, the viable cell number was determined by live cell stain-
ing using 0.4% trypan blue (w/v) (Sigma), followed by counting
with Neubauer chamber. A Schwann cell suspension was pipetted
onto the surface of the dry scaffolds at a density of 2  104
cells/well. Wells were then filled with culture medium to reach
the final volume of 500 lL; the plate was then placed into a cell
culture incubator, and cells were maintained at 37 C with 5.0%
CO2 for different time points (1, 3, and 7 days). We chose to per-
form the experiments with a cell line because primary SCs rapidly
stop their metabolic activity in the absence of axons and begin to
downregulate many myelin constituents, thus hindering cell biol-
ogy studies. Several studies have shown that the rat Schwann cells
cell line RT4-D6P2T is a practical alternative and an appropriate
model for these kinds of studies [59,60].
2.4.1. Cell metabolic studies
To measure the metabolic activity of Schwann cells seeded in
scaffolds, PrestoBlue Cell Viability Reagent (Thermo Fisher Scien-
tific) was used. At the first time point (day 1), 50 lL of 9% Presto-
Blue (w/v) in DMEM was added to each well as an indicator of
viable cells. After incubation at 37 C for 30 min, the solution of
PrestoBlue/DMEM was transferred into a new well plate, and fluo-
rescence between 535 and 590 nm was assessed using a CLARIOs-
tar plate reader. Then, cells were rinsed with PBS, and 500 lL of
DMEMwas added to each well. Scaffolds with cells were incubated
at 37 C, and the metabolic assay was repeated on days 3 and 7.
2.4.2. Dna assay
To determine the seeding efficiency and cell growth on the scaf-
folds, DNA was quantified by a fluorometric DNA assay on cell
lysates. At each time point, the mediumwas removed and scaffolds
with cells were rinsed with PBS, dried, and transferred to a new
Eppendorf tube. Each scaffold was frozen at 80 C for at least
24 h. Then, samples were thawed, and the DNA content was mea-
sured using a CyQuant cell proliferation assay kit (Invitrogen) fol-
lowing the manufacturer’s instructions. Samples were incubated
with 250 lL of Proteinase K (VWR) digestion buffer (1 mg/mL Pro-
teinase K in Tris-EDTA digestion buffer) at 56 C for 16 h. Forty
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and treated with 40 lL/well RNAse for 1 h at room temperature
to assure DNA specificity. Then, 80 lL of CyQuant reagent dye
was added, the samples were incubated for 15 min in the dark at
room temperature, and fluorescence signals (excitation 485 nm,
emission 520 nm) were detected using the CLARIOstar plate
reader. DNA quantification was performed using a standard curve
ranging from 0.5 lg/mL to 2 lg/mL of kDNA, provided by the man-
ufacturer. The number of cells was calculated assuming that
approximately 6.6 pg of DNA is present in each mammalian cell
as also described in literature [61].
2.4.3. Neosynthesized gags quantitation
To quantify GAGs produced by cells seeded on scaffolds during
culture, spectrophotometric assays based on 1,9-
dimethylmethylene blue (DMMB) solution (38 mM DMMB,
9.5 mM HCl, 40.5 mM glycine, 40.5 mM NaCl in water, pH 3) were
performed. The DMMB solution was stable for at least 4 months
when stored at room temperature in the dark. To extract GAGs
from cells at 1-, 3-, and 7-day time points, the medium was
removed, and scaffolds with cells were rinsed with PBS and frozen
at 20 C for at least 24 h. Then, samples were incubated with
250 lL of Proteinase K (VWR) digestion buffer (1 mg/mL Proteinase
K in Tris-EDTA digestion buffer) at 56 C for 16 h. Twenty-five
microliters of each sample was transferred into a black 96-well
plate. Five microliters of 2.3 M NaCl and filtered DMMB solution
(150 lL) was added into each well. The absorbance was directly
measured at 525 nm using the CLARIOstar plate reader. A standard
curve ranging from 1 lg/mL to 10 lg/mL was generated by using a
standard GAG solution (chondroitin 4-sulfate) dissolved in Protei-
nase K digestion buffer with 10 lg cysteine in 1 mL PBE (0.2%).
2.4.4. Immunostaining and fluorescence microscopy analyses
Schwann cells were fixed for 20 min with 4% (w/v)
paraformaldehyde at 4 C and rinsed several times with PBS. Cells
were permeabilized with 0.1% (v/v) Triton X-100 (VWR) in PBS for
15 min at room temperature and then incubated in blocking solu-
tion containing 1% (w/v) bovine serum albumin (BSA, VWR), 5% (v/
v) goat serum (Sigma), and 0.05% (v/v) Tween-20 (VWR) in PBS for
1 h. Afterwards, cells were incubated with primary antibody over-
night at 4 C. The primary antibodies used were anti-laminin b2c1
rabbit antibody (1:250, BioConnect), anti-integrin a9b1 mouse
antibody (1:1000, Abcam), anti-syndecan 1 mouse antibody
(1:1000, Abcam), and anti-syndecan 4 rabbit antibody (1:500,
BioConnect). Cells were extensively washed with 1% BSA and
0.05% Tween 20 in PBS and incubated with secondary antibody
for 1 h at room temperature. Alexa Fluor-488 goat antimouse and
Alexa Fluor-647 goat antirabbit (both 1:500, Invitrogen) were used
as secondary antibodies. F-actin was visualized by incubating cells
with Phalloidin Alexa Fluor 568 (5 lL/205 lL in washing buffer,
Thermo Fisher Scientific). Nuclei were counterstained with 4,6-
diamidino-2-phenylindole (DAPI) (for 5 min at 0.1 lg/mL; Sigma).
Cells were extensively washed with PBS and mounted in Mowiol
4–88 (Sigma) at 4 C until imaging. Samples were examined by flu-
orescence microscopy, and images were obtained with a Nikon
Eclipse Ti2 inverted microscope. Image adjustments were limited
to contrast enhancement and level settings using Nikon NIS Ele-
ments software and Fiji image processing package (GNU General
Public License).
2.4.5. Western blotting analyses
At each time point, cells were placed on ice, washed with ice-
cold PBS, and subjected to lysate treatment. Lysis buffer included
complete protease inhibitors (Sigma), 2 mM phenylmethylsulfonyl
fluoride (PMSF, Sigma), and 84.7% v/v RIPA buffer (Sigma). To min-
imize the presence of cell debris, protein lysates were centrifuged(10000 xg) for 10 min at 4 C, and the supernatant was collected
and stored at 80 C. To detect Syndecan 4 neoepitopes, protein
lysates were pretreated with Heparinase II (2.5 mU/lg protein,
Sigma) overnight at 37 C. Protein samples were quantified with
Pierce BCA protein assay kit (Thermo Fisher Scientific) and treated
with an equal amount of Laemmli Sample buffer (Bio-Rad) added
with 10% 2-mercaptoethanol (Sigma) at 100 C for 5 min. For
immunodetection, 10 lg of proteins from each sample was loaded,
and the proteins were separated in 4–15% Mini-PROTEAN TGX
Stain-Free Gel (Bio-Rad) and transferred by electroblotting to PVDF
membranes (Bio-Rad). Membranes were blocked with 2.6%
Blocking-Grade buffer (Bio-Rad) in TBST (0.1% Tween 20 in TBS)
and incubated overnight at 4 C in the same solution with anti-
laminin b2c1 rabbit antibody (1:250, BioConnect), anti-integrin
a9b1 mouse antibody (1:500, Abcam), anti-syndecan 1 mouse
antibody (1:250, Abcam), anti-syndecan 4 rabbit antibody (1:250,
BioConnect), anti-p75 NGF receptor rabbit antibody (1:500
Abcam), and anti-b-actin mouse antibody (1:2500, Sigma). Goat
antirabbit IgG and goat antimouse IgG, conjugated with horserad-
ish peroxidase from Bio-Rad (1:1500 dilution), were used as sec-
ondary antibodies. Following incubation with chemiluminescence
western blot substrate (Clarity Western ECL Blotting Substrate,
Bio-Rad), Grayscale images were acquired using ChemiDoc XRS
System (Bio-Rad) and analyzed by using Fiji software (GNU Gen-
eral Public License). Band intensities of each marker were normal-
ized using b-actin as the housekeeping protein.
2.4.6. Proteomic analyses
NanoLC-MS/MS SWATHTM analyses were performed on Sch-
wann cell lysates from R, RG, A, and AG scaffolds after 7 days of cul-
ture. Three replicates of each culture condition were produced for
proteomic analyses. Schwann cells on scaffolds were directly lysed
in lysis buffer (50 mM Tris HCl, 1% Triton X100, 0.25% Sodium
dodecyl cholate, Protease Inhibitor), vortexed for 30 min, frozen
for 10 min, and finally sonicated for 15 min. After centrifugation
at 16,000 xg for 10 min, the supernatant was collected, and protein
concentration was measured through BCA assay. The detergent
was removed through a column (Detergent removal column
Pierce), and 50 mg of protein was processed by adding 10% acetoni-
trile (ACN, Romil, UK) in 50 mM ammonium bicarbonate, and
5 mM dithiotreitol at 80 C for 20 min, followed by alkylation with
10 mM iodoacetamide in the dark at 37 C. Digestion was per-
formed by incubating the substrate with trypsin (Roche, Germany)
(enzyme:protein ratio, 1:100) overnight at 37 C. Samples were
acidified and then loaded on a C18 cartridge to purify peptides;
solutions were evaporated in few minutes in SpeedVac (Savant)
and eventually diluted to a final volume of 100 mL with 2%
ACN/0.1% formic acid (FA); 3 mL of the sample was injected for
library generation and a duplicate of 2 mL of each sample for
SWATHTM method analysis. Chromatographic separation of pep-
tides was performed using a nano-HPLC system (Eksigent, AB
Sciex, USA). Samples were loaded in a precolumn cartridge
(PepMap-100 C18 5 mm 100 A, 0.1  20 mm, Thermo Fisher Scien-
tific, USA) and then separated in a C18 PepMap-100 column (3 mm,
75 mm  250 mm, Thermo Fisher Scientific, USA) at a flow rate of
300 nL min1. Runs were performed with eluent A (ultrapure
water, 0.1% FA) under 60 min of linear gradient from 5% to 40%
of eluent B (ACN/0.1% FA), followed by 10 min of a purge step
and 20 min of the re-equilibration step. Peptides eluted from chro-
matography were directly processed using a TripleTOFTM 5600-ESI
mass spectrometer (AB Sciex, USA). Data were acquired using the
SWATHTM method for shotgun data-independent MRM quantifica-
tion. Library was generated by processing MS/MS data through
ProteinPilotTM Software (AB Sciex, USA).
Differentially expressed proteins were mapped onto
STRING v10 to build functional protein association networks with
192 M. Idini et al. / Acta Biomaterialia 96 (2019) 188–202reliability score higher than 0.4. STRING v10 is a database of known
and predicted physical/functional protein associations based on
four sources: genomic context, high-throughput experiments,
co-expression, and previous knowledge of functional protein
association networks.2.5. Statistical analysis
Each experiment was carried out in triplicates, except for west-
ern blot (quadruplicates). All results are presented as mean ± stan-
dard deviation (SD). GraphPad Prism software v 4.03 (GraphPad,
San Diego, CA, USA) was used to perform statistical analysis. Statis-
tical significance was set at a p-value  0.05.
For proteomics data obtained by mass spectrometry, the false
discovery rate (FDR) analysis was set to a confidence level of
95%. The comparative analysis was performed using PeakViewTM
Software (ABSciex, USA) with MS/MS (ALL) in SWATHTM Acquisition
MicroApp 2.0 and MarkerViewTM (AB Sciex, USA). Retention time
alignment was obtained using selected peptides (top confidence
and top-level transitions) from top score protein. Processing set-
tings were 7 peptides per protein, 7 transitions per peptide, 93%
peptide confidence (according to Paragon algorithm result), and
5% FDR; XIC options: extraction window 10 min, width 50 ppm,
and 0.1 Da. Normalization was done using a global normalizationFig. 1. Dispersion analysis of the two typologies of fabricated PCL scaffolds. Represe
speed = 4000 rpm) fibers (panels A and B, respectively) and the corresponding directiona
dispersion average and standard deviation in both random and aligned fibers (panel E).of total ion profiles (total protein content). Principal Component
Analysis (PCA) was performed to evidence groupings among the
data set. Groups were compared with t-test using a threshold of
95% (p value = 0.05) and fold change > 2.3. Results
3.1. Electrospun scaffold fabrication
To determine how the rotation of a grounded mandrel affects
the scaffold structure, the mandrel speed was set at 500 and
4000 rpm. Under baseline conditions (mandrel rpm = 500) PCL
solution produced scaffolds composed of 1.34 (±0.23) lm diameter
fibers. At 4000 rpm mandrel speed, scaffolds were made up of 1.35
(±0.04) lm diameter fibers. In both cases, fibers had a diameter
similar to that of collagen bundles [62]. Fibers produced with dif-
ferent mandrel speeds had a rounded cross-sectional profile, and
the mandrel rotation did not alter the average fiber diameter.
The fiber alignment was crucial to mimic the oriented pattern of
collagen fibrils found in the ECM during nerve regeneration
[62,63]. In this aspect, scaffold images obtained with SEM showed
that fibers obtained with a mandrel speed of 4000 rpm were
aligned compared to the fibers in scaffolds produced at 500 rpm
mandrel speed. As illustrated in Fig. 1, analysis revealed that thentative SEM images of random (mandrel speed = 500 rpm) and aligned (mandrel
lity histograms (panels C and D) obtained by using Fiji software. Histogram showing
M. Idini et al. / Acta Biomaterialia 96 (2019) 188–202 193dispersion of fibers was much narrower for scaffolds with aligned
fibers than for scaffolds with random fibers, indicating that aligned
fibers achieved a higher degree of orientation.
3.2. Gag analysis
GAGs were purified from porcine vascular tissue. Quantitative
analysis evidenced GAG levels corresponding to 3.50 (±0.08) lg
UA/mg dry weight and 1.17 (±0.03) lg UA/mg fresh weight.Fig. 2. Scaffold sterilization. From left to right: scaffolds sterilized with EtOH before
functionalization with GAGs, scaffolds functionalized without the sterilization step,
and scaffolds sterilized after crosslinking reaction. The amount of GAGs used to
functionalize scaffolds was 100 lg. **p < 0.01.
Fig. 3. Histograms showing metabolic and proliferation activities, as well as GAG and tot
metabolic activities assessed by Presto Blue assay. (B) Proliferation activity measured
biosynthesis assessed by BCA assay. Abbreviations: R = random, RG = random with GA
interpretation of the references to colour in this figure legend, the reader is referred toQualitative analysis showed the following GAG distribution in aor-
tic wall in accordance with data previously reported by Naso et al.
[54]: 60% chondroitin sulfate, 20% dermatan Sulfate, 13% heparan
sulfate, and 7% hyaluronan (Supplementary Information, Fig. S2).
Fine structural characterization of CS isomers showed that they
were composed of 3% 4,6S disaccharide units, 47.9% 4S disaccha-
ride units, 45.5% 6S disaccharide units, and 3.6% non-S disaccharide
units, according to our previous study [55].
3.3. Scaffold functionalization
To evaluate the efficiency of PCL crosslinking with GAGs puri-
fied from aorta porcine tissue, an Alcian Blue staining protocol
was developed. Compared to their corresponding controls, scaf-
folds pretreated with HMDA had a percentage of GAG coating
higher than that in scaffolds hydrolyzed with NaOH (Supplemen-
tary Information Fig. S3).
Regarding scaffold sterilization, another experiment was set up
to verify the efficiency of functionalization associated with a step
of 2 h in 70% ethanol before or after the crosslinking reaction
(Fig. 2). Functionalization was more efficient when scaffolds were
not sterilized or when a sterilization step was preceded by the
crosslinking reaction. Since aminolysis reaction occurs in iso-
propanol, we chose not to sterilize scaffolds, hence avoiding an
additional step in the protocol. Indeed, scaffolds incubated with
100 mg of GAGs without EDC-NHS showed no differences with
regard to scaffolds incubated with EDC-NHS without GAGs.al protein production in Schwann cells during 7 days of 3D scaffold culture. (A) Cell
by DNA assay. (C) Biosynthesis of GAGs assessed by DMMB assay. (D) Protein
Gs, A = aligned, AG = aligned with GAGs. *p < 0.05, **p < 0.01, ***p < 0.001. (For
the web version of this article.)
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to the scaffold and validated the efficacy of EDC-NHS crosslinking
in creating GAG-functionalized polymer nanofibers.
3.4. Cell studies
Results of metabolic activity (Fig. 3A) and proliferation (Fig. 3B),
as well as GAGs and total protein production (Fig. 3C, D) by Sch-
wann cells seeded in the four topologies of fabricated scaffolds,
showed an overall increase in these activities during the 7 days
of culture. The presence of GAGs reduced cell metabolic activity
and GAG production in random scaffolds but did not have an effect
on aligned fibers.
Immunofluorescence analysis clearly showed that Schwann
cells seeded in scaffolds with aligned fibers had an elongated shape
that followed the direction of the fibers. Conversely, cells seeded in
scaffolds with random fibers assumed a spreaded morphology
(Fig. 4). Furthermore, cells expressed laminin (Fig. 5), a9b1 integrin
(Fig. 6), syndecan 1 (Fig. 7), and syndecan 4 (Fig. 8) on the scaffolds.
The same proteins, as well as p75, were quantified by western blot
analysis (Fig. 9). a9b1 Integrin is a widely distributed multifunc-
tional receptor that interacts with a variety of endogenous ligands
and ECM components. Furthermore, this isoform is a receptor for
nerve growth factor (NGF) and two other neurotrophins, namely,
brain-derived neurotrophic factor and NT3 [64]. a9b1 Integrin
showed decreased levels from days 1 to 3 and day 7 (Fig. 9A),
although not statistically significant. This protein is known to be
involved in focal adhesion in association with Syndecan 4. Interest-
ingly, Schwann cells seeded in functionalized scaffolds withFig. 4. Representative immunofluorescence images of Schwann cells seeded on both ran
culture. F-actin is shown in red (Phalloidin-Alexa Fluor 568 staining) and nuclei in blue (D
reader is referred to the web version of this article.)aligned fibers experienced a significant increase in Syndecan 4
expression (Fig. 9B) from days 3 to 7, in contrast to cells seeded
in other scaffolds that did not exhibit significant changes during
the same period. Moreover, the aligned functionalized scaffolds
achieved an overall higher Syndecan 4 levels on day 7 than cells
seeded in aligned nonfunctionalized scaffolds and both random
fiber conditions. This shows that a combination of functionaliza-
tion with GAG and topography of scaffolds is needed for increased
expression level of Syndecan 4.
Furthermore, we observed similar patterns comparing protein
levels between a9b1 Integrin and Syndecan 1 (Fig. 9C) on days 3
and 7, probably because of their colocalization in the plasma mem-
brane. Laminin showed significantly decreased levels from days 1
to 7 in cells seeded in nonfunctionalized scaffolds with aligned
fibers (Fig. 9D). Although the trend was a reduction in the assessed
markers during 7 days of culture, an overall increase in protein
expression was observed in Schwann cells seeded in functionalized
scaffolds (Fig. 3D), both random and aligned, on day 7 of culture,
suggesting that, following a lag phase, Schwann cells started to
produce ECM proteins themselves. Furthermore, the expression
of p75 (or low-affinity nerve growth factor receptor), a Schwann
cell marker, was evaluated (Fig. 9E), which showed a considerable
decrease from days 1 to 3 and day 7, particularly evident for cells
seeded in nonfunctionalized aligned fibers. Overall, all the proteins
studied showed a similar trend with increased levels on day 7 in
cells seeded in functionalized scaffolds with aligned fibers com-
pared to those of cells seeded on nonfunctionalized scaffolds with
aligned fibers (Fig. 3D), even though these data were significant
only regarding Syndecan 4.dom and aligned fibers with or without cross-linked GAGs at each time point of cell
API staining). (For interpretation of the references to colour in this figure legend, the
Fig. 5. Representative immunofluorescence images of Schwann cells seeded on both random and aligned fibers with or without cross-linked GAGs at each time point of cell
culture. Laminin is shown in purple (Alexa Fluor-647 staining) and nuclei in blue (DAPI staining). (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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The adopted proteomic approach allowed for the identification
of 559 and 872 unique proteins on days 3 and 7, respectively, as
shown in Supplementary Information Tables S1 and S2. Compara-
tive analysis evidenced a panel of proteins differentially expressed
with a p value < 0.05 and a fold change > 2 (Supplementary infor-
mation). Proteomics data compared the 4 conditions on the same
day of culture. Results of protein–protein interaction network anal-
ysis performed with STRING v10 software showed a greater mod-
ulation on GAG-functionalized scaffolds than that of the
nonfunctionalized ones, although only few modulated proteins
were found comparing fiber orientations. This behavior was sum-
marized in PCA on days 3 (Fig. 10A) and 7 (Fig. 10B), where the
presence of GAG more than the different alignments of fibers have
driven group formation: GAG-functionalized scaffolds grouped clo-
ser vs. non-functionalized ones.
On day 3, many binding proteins (TNR16, NLTP, MAP1B, SSBP,
DREB, and SEPT9) were downregulated in GAG-functionalized scaf-
folds, while other DNA/RNA-binding proteins (RAB14, RS15,
HNRH2, and PA2G4), as well as growth regulation protein
(PA2G4), were upregulated (Supplementary Information, Tables
S3–S6 and Figs. S5–S8).
The proteomic approach found a greater difference on day 7,
with evidence of final effectors indicating a general growing pro-
cess. No significant difference was detected in cell total protein
secretion and proliferation when comparing functionalized and
nonfunctionalized scaffolds. Cells grown on GAG-functionalized
scaffolds experienced a general downregulation, especially for pro-teins involved in cell cycle, synthesis, and metabolism (Supple-
mentary information, Tables S7–S10 and Figs. S9–S12). RG
samples on day 7 exhibited a downregulation of transcription fac-
tors (PTMA, HP1B3, and HDGR2), translation (EIF3I), and RNA-
binding proteins (RL28, RL3, ICAL, CELF1, LPPRC, RL10, and LPPRC),
and protein complex assembly (NCLN and NASP) with regard to the
corresponding R samples (Supplementary Information, Table S9,
Fig. S11); this is in agreement with the corresponding metabolic
and proliferation activity tests. Downregulation of metabolic pro-
cess and kinase proteins (OLA1, DCLK1, PDXK, NDKB, KAD3,
CP51A, AMPL, and NUCKS), as well as cell adhesion molecules
(SDC4, 1433B, MARCS, PARVA, and PLPC), was also evident in AG
fiber meshes compared to A scaffolds (Supplementary Information
Table S7 Fig. S9). The apparent contrast between the reduced Syn-
decan 4 (SDC4) detection and the decisive increase shown by west-
ern blot can be resolved when considering that Syndecan 4 is a
transmembrane protein with an extracellular domain that can be
cleaved or ‘shed’ under certain conditions [65]. The western blot
data measure the intracellular domain, while the proteomic analy-
sis detects a fragment in the extracellular domain of Syndecan 4; if
this domain was already shed at the time of sample preparation, it
would not be detected by proteomic analysis. Through this com-
bined analytical approach, we show that Syndecan 4 expression
increases and indirectly may reveal an increase in Syndecan 4,
shedding in the aligned functionalized scaffold condition. Interest-
ingly, GAG functionalization also resulted in an upregulation of
prosaposin, a glycoprotein with reported neurotrophic activity
[66], while aligned fibers resulted in an upregulation of lamin-B1
among others (Supplementary Information Table S8, Fig. S10).
Fig. 6. Representative immunofluorescence images of Schwann cells seeded on both random and aligned fibers with or without cross-linked GAGs at each time point of cell
culture. Integrin is shown in green (Alexa Fluor-488 staining) and nuclei in blue (DAPI staining). (For interpretation of the references to colour in this figure legend, the reader
is referred to the web version of this article.)
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PNI is one of the major clinical problems in restorative medicine
and microsurgery, caused primarily by lacerations, fractures, pen-
etrating stretching, or crushing trauma. An estimated 2.8% of
trauma patients experience some form of PNI; this number reaches
5% if plexus and root lesions are included [67]. Despite progress in
surgical techniques, functional recovery after a serious lesion of a
nerve trunk is often incomplete and inadequate.
In contrast with the axons in the central nervous system,
peripheral axons have the ability to regenerate. Schwann cells
are critical supporting cells of peripheral neurons, participating
in neural development, by driving axons to extend to their appro-
priate terminal organs and promoting nerve repair by facilitating
axonal elongation over long distances during axonal regeneration
after peripheral nerve injury. In particular, Schwann cells migrate
from both proximal and distal nerve stumps to the injury site,
where they form the bands of Büngner after Wallerian degenera-
tion [68,69]. Schwann cells also stimulate the elongation of regen-
erating axons over longer distances by secreting neurotrophins,
such as nerve growth factor [70], which are transported to the neu-
ral cell body [71].
Several animal studies have shown that early reinnervation of
the end organ is of primary importance for an acceptable func-
tional recovery. Delay in repairing an injured nerve represents a
huge clinical problem, as it could cause changes that make nerve
fibers unable to regenerate, and the muscles undergo atrophy
and lose the ability to be reinnervated [72]. Accordingly, research-
ers are constantly trying to develop strategies to increase the ther-
apeutic success rate of regeneration and functional recovery. Inthis aspect, a multidisciplinary approach to solve some of the most
demanding medical problems is represented by scaffold-based
regenerative medicine strategies, which are trying to match the
most suitable synthetic polymer formulations with specific bio-
chemical signals to obtain useful constructs in tissue regeneration.
In this study, electrospun PCL scaffolds were produced using a
mandrel. Two different speeds were applied to obtain two types
of scaffolds with random or aligned fibers. In both cases, microfi-
bers had a diameter of approximately 1.3 lm, a fiber diameter sim-
ilar to that of collagen fiber bundles [62]. To investigate the role of
GAGs on Schwann cell growth on a polymeric support, scaffolds
were functionalized through a cross-linking reaction, which allows
GAGs to be covalently bound to the fibers. GAGs are among the
major constituents of the ECM and are involved in several physio-
logical and pathological processes [31]. In the PNS, GAGs are
known to mediate proliferation, synaptogenesis, neural plasticity,
and regeneration [32–34,73]. To evaluate the role of GAGs in nerve
regeneration, Schwann cells were seeded on functionalized and
nonfunctionalized scaffolds with either random or aligned fibers.
After 1, 3, and 7 days of culture, metabolic activity, proliferation,
and GAGs assays were performed. Furthermore, the expression of
five specific markers was assessed by both immunofluorescence
and western blot analyses. Among them, syndecan 1, a transmem-
brane proteoglycan, is known to be involved in cytoskeletal reorga-
nization and in attachment of cells to ECM, whereas syndecan 4 is
known to bind different proteins in ECM and to promote focal
adhesion in co-localization with integrins. Additionally, we evalu-
ated the expression of p75, a marker of differentiation in Schwann
cells, and of laminin, one of the most abundant ECM proteins in the
PNS.
Fig. 7. Representative immunofluorescence images of Schwann cells seeded on both random and aligned fibers with or without cross-linked GAGs at each time point of cell
culture. Syndecan 1 is shown in green (Alexa Fluor-488 staining) and nuclei in blue (DAPI staining). (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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chosen to obtain a complete map of Schwann cells grown on non-
functionalized and GAG-functionalized scaffolds on days 3 and 7,
with day 7 being the only time point with a sufficient number of
cells and total protein content for a more robust proteomics profil-
ing. The resulting proteomics library provided a comparison
between Schwann cells differentially activated by GAG-
functionalized and nonfunctionalized scaffolds.
Overall, cell studies showed that cells increased their metabolic
and proliferation activities over 7 days in culture, as well as GAG
production. Whereas the alignment of fibers only had a consider-
able influence on cell morphology, resulting in their elongation,
no other marker was affected. Conversely, the functionalization
with GAGs resulted in an increase in cell proliferation and GAG for-
mation at very early time points (day 1). There was also a signifi-
cantly higher expression of Syndecan 4 in GAG-functionalized
aligned fibers than in GAG-functionalized random fibers and to
nonfunctionalized scaffolds, indicating that both fiber topography
and GAG functionalization lead to an increase in Syndecan 4
production.
In general, proteomic analysis revealed a high modulation
between conditions for day 7 cultures. Although not statistically
significant, a general downregulation of synthetic processes for
cells cultured on GAG-functionalized scaffolds was evidenced (RG
vs. R, Fig. 3), confirming trends observed in biochemical metabolic
and proliferation data. Indeed, a combination of the highly sensi-
tive mass spectrometry technique with more classical biochemicaland immunohistochemical analyses could enable the detection of
aspects that could not be otherwise identified.
For example, Syndecan 4 was found to be significantly down-
regulated by more than 5-fold in AG than in A, while its expression
assayed through western blot analysis seemed to contradict this
finding. Syndecan 4 is a transmembrane proteoglycan and is
known to bind to a number of ECM molecules and form receptor
complexes that bind growth factors and cytokines, subsequently
triggering intracellular signaling processes [74]. Syndecan 4 has
been shown to influence cell migration and focal adhesion turn-
over, having a significant role in wound healing and angiogenesis,
and it mediates signaling for FGF and other heparin-binding
growth factors [74–76]. Furthermore, the expression of
Syndecan-4 is increased in response to inflammatory stimuli and
this versatile proteoglycan subsequently undergoes ‘‘shedding,”
whereby the extracellular domain is cleaved and locally modifies
the extracellular milieu [77]. Despite having no direct proof in
our results that Syndecan-4 shedding has taken place, from what
is known in literature, these shed fragments have been shown to
block the inhibition of proteases, promoting matrix remodeling
during tissue repair, and have been suggested to sequester growth
factors, thereby reducing local chemokine concentrations [78,79].
The removal of the Syndecan 4 ectodomain from the cell surface
has been shown to promote cell mobility [65]. This implies that
this scaffold has the potential to trigger increased cell migration
and matrix remodeling, both essential activities for successful
nerve repair.
Fig. 8. Representative immunofluorescence images of Schwann cells seeded on both random and aligned fibers with or without cross-linked GAGs at each time point of cell
culture. Syndecan 4 is shown in purple (Alexa Fluor-647 staining) and nuclei in blue (DAPI staining). (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
Fig. 9. Histograms showing levels of selected markers expressed by Schwann cells seeded in the four constructs during 7 days of culture, obtained by western blot analysis.
(A) Integrin. (B) Syndecan 4. (C) Syndecan 1. (D) Laminin. (E) p75. Data are normalized for b-actin expression. *p < 0.05, **p < 0.01.
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Fig. 10. Principal Component Analysis (PCA) at days 3 (panel A) and 7 (panel B). PCA is a statistical analysis that gives a score to each sample (axes represent the scores) so to
represent how much the samples are far or close to each another. Close samples means that their profiles are similar.
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upregulation in AG and RG, respectively, reflected glycoprotein
increase in functionalized samples already seen on day 7 for AG
samples in GAG assay (Fig. 3). SAP, in particular, is a known neu-
rotrophic factor that has been shown to promote peripheral nerve
repair [80]. Myristoylated alanine-rich C-kinase substrate
(MARCKS) plays important roles in cell shape, cell motility,secretion, transmembrane transport, regulation of the cell cycle,
and neural development [81].
Cell adhesion molecules were downregulated in functionalized
samples, mirroring the general trend of reduction of the assessed
markers during 7 days of culture (Fig. 9). The reduced expression
of HDG2, known to promote cell growth [82] and DNA repair
[83], further corroborates data from proliferation assay for RG
200 M. Idini et al. / Acta Biomaterialia 96 (2019) 188–202samples. Similarly, the observed reduction in metabolic activity
was reflected in the downregulation of CP51A, a cytochrome
P450 isoenzyme that serves in the metabolism and biosynthesis
of steroids, lipids, and vitamins.
In this study, we have focused on early response of Schwann
cells to GAGs motifs functionalized on the surface of microfibrous
meshes. Future studies will have to investigate longer culturing
times to better assess the potential of GAG-functionalized scaffolds
for neural regeneration. Such studies will have to be followed by
validation in vivo, where it will be also important to assess the
influence of the local inflammatory microenvironment. It is known,
in fact, that macrophages play a pivotal role in eliminating inhibi-
tory substances from the nerve regenerative microenvironment
[84]. Altogether, our results suggest that GAG-functionalized scaf-
folds may have the potential to create an extracellular environ-
ment similar to that of the natural Schwann cell basal lamina.
Moreover, increased levels of Syndecan 4 in functionalized scaf-
folds with aligned fibers indicate that this proteoglycan may lead
Schwann cells to a localized ECM environment after nerve injury
where ECM proteins, such as fibrin, form cables capable to conduct
nerve regeneration [85].5. Conclusions
Although nerve fibers of the PNS have a remarkable ability to
regenerate because of primarily Schwann cells, post-traumatic
functional recovery after a severe lesion of a major nerve trunk is
often incomplete and unsatisfactory. In this aspect, a major chal-
lenge of tissue engineering is to develop a synthetic scaffold with
both mechanical and biochemical properties (i.e., biocompatibility,
controlled biodegradability with nontoxic products, low inflamma-
tory potential, and porosity) that promotes cell attachment and
growth during the regenerative process.
Actually, several synthetic polymers and natural materials are
used to fabricate scaffolds with the required properties by electro-
spinning, nanofiber self-assembly, liquid–liquid phase separation,
solvent casting and particulate leaching, emulsification/freeze-
drying, gas foaming, and additive manufacturing. Biocompatibility
of engineered scaffolds is often enhanced by surface modification
of the material, in particular, by attaching bioactive molecules.
Two well-defined fiber deposition patterns were presented
(aligned or random fibers), which we successfully functionalized
with GAGs purified from aorta porcine tissue and assessed for their
potential as support for Schwann cell adhesion, growth, and differ-
entiation, by both classical biochemistry and LC-MS-based pro-
teomic profiling. The latter allowed to obtain a complete protein
profile of Schwann cells as well as to identify differentially
expressed proteins between cells grown on different constructs.
Comparing results obtained from these quite different approaches
allowed us to show that PCL–GAG scaffolds could represent a
promising artificial substrate that closely mimics the recently
established pattern of Schwann cell migration into the regenerat-
ing nerve.Data availability
Data are available from the corresponding author, upon request.
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